CDAK Past Earnings image   This CDAK past earnings page last updated 8/8/2022
CDAK Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/4/2022-0.300
Q1 20225/5/2022-0.360
Q4 20213/10/2022-0.750
Q3 202111/4/2021-0.970
Q2 20218/5/2021-0.990
Q1 20215/6/2021-0.510
Q4 20203/17/2021-1.140
Q3 202011/19/2020-12.830
CDAK Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/4/20220.01B
Q1 20225/5/20220.01B
Q4 20213/10/20220.01B
Q3 202111/4/20210.00B
Q2 20218/5/20210.00B
Q1 20215/6/202113.19M
Q4 20203/17/20210.00B
Q3 202011/19/20200.00B
Quotes delayed 20 minutes

Email EnvelopeFree CDAK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Codiak BioSciences (CDAK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CDMO Past Earnings
CDNA Past Earnings
CDRE Past Earnings
CDTX Past Earnings
CDXC Past Earnings
CELC Past Earnings
CEMI Past Earnings
CERC Past Earnings
CERS Past Earnings
CFMS Past Earnings

CDAK Past Earnings Q&A

What was the best and worst CDAK past earnings results?
For Codiak BioSciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CDAK past earnings result in our data set was -0.300/share posted in Q2 2022, while the lowest was in Q3 2020 when CDAK posted -12.830/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2021 when CDAK reported 13.19M in revenue, while the quarter with the lowest revenue in our data set was Q2 2021 at 0.00B of revenue.

  Suggested answer: There are 8 CDAK past earnings results in our data set.

On this page we presented the CDAK past earnings date information for Codiak BioSciences. Reviewing that CDAK Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2022, when CDAK posted gaap of -0.300/share. Meanwhile the lowest CDAK past earnings result was in Q3 2020, when CDAK posted gaap of -12.830/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2021 when CDAK reported 13.19M in revenue, while the smallest revenue quarter was Q2 2021 when CDAK reported 0.00B in revenue.

Any self directed investor doing their due diligence on CDAK or any other given stock can benefit from researching all of the Codiak BioSciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Codiak BioSciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CDAK. Thanks for visiting, and the next time you need to research CDAK past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: QCCO Insider Buying, CMPR shares outstanding history, Top Ten Hedge Funds Holding PBIB.

 

CDAK Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.